Helical tomotherapy as a new treatment technique for whole abdominal irradiation

Strahlentherapie und Onkologie

Volumn 184, Issue 3, 2008, Pages 145-149

  Rochet, Nathalie ^a,c   Sterzing, Florian ^a   Jensen, Alexandra ^a   Dinkel, Julien ^b   Herfarth, Klaus ^a   Schubert, Kai ^a   Eichbaum, Michael ^a   Schneeweiss, Andreas ^a   Sohn, Christof ^a   Debus, Juergen ^a   Harms, Wolfgang ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

4D CT; Advanced ovarian cancer; IMRT; Tomotherapy; Whole abdominal irradiation

Indexed keywords

CARBOPLATIN; PACLITAXEL;

ABDOMINAL RADIOTHERAPY; ADULT; ADVANCED CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURGERY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HELICAL TOMOTHERAPY; HUMAN; INTENSITY MODULATED RADIATION THERAPY; OVARY CANCER; PERITONEAL CAVITY; RADIATION DOSE; TREATMENT PLANNING;

ABDOMEN; ALGORITHMS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE MARROW; CARBOPLATIN; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; KIDNEY; LIVER; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; OVARY; PACLITAXEL; PROSPECTIVE STUDIES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, ADJUVANT; RADIOTHERAPY, INTENSITY-MODULATED; TIME FACTORS; TOMOGRAPHY, SPIRAL COMPUTED; TREATMENT OUTCOME;

EID: 40549142368     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-008-1772-z     Document Type: Article

References (24)

1. Combs SE, Konkel S, Thilmann C, et al. Local high-dose radiotherapy and sparing of normal tissue using intensity-modulated radiotherapy (IMRT) for mucosal melanoma of the nasal cavity and paranasal sinuses. Strahlenther Onkol 2007;183:63-8.
2. Dobler B, Lorenz F, Wertz H, et al. Intensity-modulated radiation therapy (IMRT) with different combinations of treatment-planning systems and linacs. Issues and how to detect them. Strahlenther Onkol 2006;182:481-8.
3. Duthoy W, De Gersem W, Vergote K, et al. Whole abdominopelvic radiotherapy (WAPRT) using intensity-modulated arc therapy (IMAT): first clinical experience. Int J Radiat Oncol Biol Phys 2003;57:1019-32.
4. Einhorn N, Lundell M, Nilsson B, et al. Is there place for radiotherapy in the treatment of advanced ovarian cancer? Radiother Oncol 1999;53:213-8.
5. Einhorn N, Trope C, Ridderheim M, et al. A systematic overview of radiation therapy effects in ovarian cancer. Acta Oncol 2003;42:562-6.
6. Fiorino C, Dell'Oca I, Pierelli A, et al. Simultaneous integrated boost (SIB) for nasopharynx cancer with helical tomotherapy. A planning study. Strahlenther Onkol 2007;183:497-505.
7. Fyles AW, Dembo AJ, Bush RS, et al. Analysis of complications in patients treated with abdomino-pelvic radiation therapy for ovarian carcinoma. Int J Radiat Oncol Biol Phys 1992;22:847-51.
8. Gershkevitsh E, Clark CH, Staffurth J, et al. Dose to bone marrow using IMRT techniques in prostate cancer patients. Strahlenther Onkol 2005;181:172-8.
9. Herfarth KK, Pirzkall A, Lohr F, et al. First experiences with a noninvasive patient set-up system for radiotherapy of the prostate. Strahlenther Onkol 2000;176:217-22.
10. Hermesse J, Devillers M, Deneufbourg JM, et al. Can intensity-modulated radiation therapy of the paraaortic region overcome the problems of critical organ tolerance? Strahlenther Onkol 2005;181:185-90.
11. Hong L, Alektiar K, Chui C, et al. IMRT of large fields: whole-abdomen irradiation. Int J Radiat Oncol Biol Phys 2002;54:278-89.
12. Hui SK, Kapatoes J, Fowler J, et al. Feasibility study of helical tomotherapy for total body or total marrow irradiation. Med Phys 2005;32:3214-24.
13. Jeanneret-Sozzi W, Moeckli R, Valley JF, et al., on behalf of SASRO. The reasons for discrepancies in target volume delineation: a SASRO study on head-and-neck and prostate cancers. Strahlenther Onkol 2006;182:450-7.
14. Kanagaki B, Read PW, Molloy JA, et al. A motion phantom study on helical tomotherapy: the dosimetric impacts of delivery technique and motion. Phys Med Biol 2007;52:243-55.
15. Mackie TR, Balog J, Ruchala K, et al. Tomotherapy. Semin Radiat Oncol 1999;9:108-17.
16. Moulder JE, Cohen EP. Renal dysfunction after total body irradiation: dose-effect relationship: in regard to Kal and van Kempen-Harteveld (Int J Radiat Oncol Biol Phys 2006;65:1228-1232). Int J Radiat Oncol Biol Phys 2007;67:319; author reply 319-20.
17. Munter MW, Nill S, Thilmann C, et al. Stereotactic intensity-modulated radiation therapy (IMRT) and inverse treatment planning for advanced pleural mesothelioma. Feasibility and initial results. Strahlenther Onkol 2003;179:535-41.
18. Ozols RF. Current controversies in ovarian cancer: maintenance chemotherapy and neoadjuvant chemotherapy as standard care. ASCO Educational Book. Alexandria, USA: American Society of Clinical Oncology, 2004.
19. Penagaricano JA, Papanikolaou N, Yan Y, et al. Feasibility of cranio-spinal axis radiation with the Hi-Art tomotherapy system. Radiother Oncol 2005;76:72-8.
20. Pickel H, Lahousen M, Petru E, et al. Consolidation radiotherapy after carboplatin-based chemotherapy in radically operated advanced ovarian cancer. Gynecol Oncol 1999;72:215-9.
21. Reinartz G, Kardels B, Koch P, et al. Analysis of failures after whole abdominal irradiation in gastrointestinal lymphomas. Is prophylactic irradiation of inguinal lymph nodes required? German Multicenter Study Group on GI-NHL, University of Muenster. Strahlenther Onkol 1999;175:601-5.
22. Sorbe B. Consolidation treatment of advanced ovarian carcinoma with radiotherapy after induction chemotherapy. Int J Gynecol Cancer 2003;13:Suppl 2:192-5.
23. Sterzing F, Munter MW, Schafer M, et al. Radiobiological investigation of dose-rate effects in intensity-modulated radiation therapy. Strahlenther Onkol 2005;181:42-8.
24. Welsh JS, Patel RR, Ritter MA, et al. Helical tomotherapy: an innovative technology and approach to radiation therapy. Technol Cancer Res Treat 2002;1:311-6.